Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
Strata Skin Sciences participates in a conference call with Ladenburg Thalmann » 10:25
08/16/22
08/16
10:25
08/16/22
10:25
SSKN

Strata Skin Sciences

$1.03 /

+0.03 (+3.00%)

Business news update…

Business news update conference call with management will be held on August 16 at 11 am hosted by Ladenburg Thalmann. Webcast Link

ShowHide Related Items >><<
SSKN Strata Skin Sciences
$1.03 /

+0.03 (+3.00%)

Hot Stocks
Strata Skin Science announces U.S. commercial launch of TheraClearX » 16:17
07/25/22
07/25
16:17
07/25/22
16:17
SSKN

Strata Skin Sciences

$1.10 /

+ (+0.00%)

STRATA Skin Sciences…

STRATA Skin Sciences announced the U.S. commercial launch of TheraClear X, a non-invasive, in-office acne treatment targeting the root causes of mild to moderate acne, including comedonal, pustular and inflammatory acne vulgaris."We're delighted to have reached this milestone in bringing TheraClearX to the U.S. market. We are confident that this technology will offer an exciting new treatment option for acne patients and dermatology professionals, as well as deliver an exciting new growth opportunity for STRATA," said CEO Bob Moccia. "We are especially excited to now offer an acne treatment through STRATA's well established "Partnership Program" which offers dermatology practices in the U.S. practical in-office treatment solutions without the need to purchase expensive equipment.

ShowHide Related Items >><<
SSKN Strata Skin Sciences
$1.10 /

+ (+0.00%)

Over a quarter ago
Conference/Events
American Academy of Dermatology to hold annual meeting » 04:55
03/29/22
03/29
04:55
03/29/22
04:55
ABBV

AbbVie

$161.95 /

+0.61 (+0.38%)

, AMGN

Amgen

$240.34 /

+1.56 (+0.65%)

, AMYT

Amryt Pharma

$8.13 /

-0.17 (-2.05%)

, BBI

Brickell Biotech

/

+

, BMY

Bristol-Myers

$73.13 /

-0.16 (-0.22%)

, RCEL

Avita Medical

$7.82 /

+0.26 (+3.44%)

, REGN

Regeneron

$693.83 /

+14.29 (+2.10%)

, SNY

Sanofi

$51.84 /

+0.3 (+0.58%)

, SSKN

Strata Skin Sciences

$1.54 /

-0.1 (-6.10%)

, VERO

Venus Concept

$1.42 /

+0.055 (+4.03%)

, ASLN

Aslan Pharmaceuticals

/

+

, CARA

Cara Therapeutics

$12.35 /

+0.025 (+0.20%)

, KRYS

Krystal Biotech

$65.66 /

+1.34 (+2.08%)

, IFRX

InflaRx

$2.30 /

-0.215 (-8.55%)

, IMUX

Immunic

$11.39 /

-0.33 (-2.82%)

, INCY

Incyte

$78.93 /

+0.46 (+0.59%)

, BHC

Bausch Health

$22.58 /

-0.24 (-1.05%)

2022 AAD Annual Meeting…

2022 AAD Annual Meeting to be held in Boston on March 25-29.

ShowHide Related Items >><<
VERO Venus Concept
$1.42 /

+0.055 (+4.03%)

SSKN Strata Skin Sciences
$1.54 /

-0.1 (-6.10%)

SNY Sanofi
$51.84 /

+0.3 (+0.58%)

REGN Regeneron
$693.83 /

+14.29 (+2.10%)

RCEL Avita Medical
$7.82 /

+0.26 (+3.44%)

KRYS Krystal Biotech
$65.66 /

+1.34 (+2.08%)

INCY Incyte
$78.93 /

+0.46 (+0.59%)

IMUX Immunic
$11.39 /

-0.33 (-2.82%)

IFRX InflaRx
$2.30 /

-0.215 (-8.55%)

CARA Cara Therapeutics
$12.35 /

+0.025 (+0.20%)

BMY Bristol-Myers
$73.13 /

-0.16 (-0.22%)

BHC Bausch Health
$22.58 /

-0.24 (-1.05%)

BBI Brickell Biotech
/

+

ASLN Aslan Pharmaceuticals
/

+

AMYT Amryt Pharma
$8.13 /

-0.17 (-2.05%)

AMGN Amgen
$240.34 /

+1.56 (+0.65%)

ABBV AbbVie
$161.95 /

+0.61 (+0.38%)

ABBV AbbVie
$161.95 /

+0.61 (+0.38%)

03/22/22 Jefferies
Vertex 'the cleanest story in large-cap biotech,' says Jefferies
03/21/22 Northland
Oaktree Acquisition Corp. II initiated with an Outperform at Northland
03/01/22 Citi
AbbVie price target raised to $170 from $155 at Citi
02/28/22 BMO Capital
Morphic price target lowered to $83 from $102 at BMO Capital
AMGN Amgen
$240.34 /

+1.56 (+0.65%)

03/22/22 Mizuho
Puerto Rico tax change could raise Amgen tax rate in 2023, says Mizuho
03/02/22 Citi
Mirati Therapeutics price target lowered to $227 from $244 at Citi
03/01/22 Mizuho
Amgen price target raised to $202 from $194 at Mizuho
03/01/22 Stifel
Stifel upgrades Revolution Medicines, sees good entry point after pullback
AMYT Amryt Pharma
$8.13 /

-0.17 (-2.05%)

03/10/22 H.C. Wainwright
Amryt Pharma price target lowered to $18 from $20 at H.C. Wainwright
03/01/22 Maxim
Amryt Pharma price target lowered to $18 from $27 at Maxim
03/01/22 Canaccord
Amryt Pharma price target lowered to $19 from $40 at Canaccord
03/01/22 H.C. Wainwright
Amryt Pharma price target lowered to $20 from $29 at H.C. Wainwright
BBI Brickell Biotech
/

+

03/08/22 William Blair
Brickell Biotech initiated with an Outperform at William Blair
01/18/22 H.C. Wainwright
Brickell Biotech initiated with a Buy at H.C. Wainwright
09/01/21 Lake Street
Brickell license deal brings 'multiple new value-drivers,' says Lake Street
04/26/21 Lake Street
Brickell Biotech Phase 3 safety results build confidence, says Lake Street
BMY Bristol-Myers
$73.13 /

-0.16 (-0.22%)

03/21/22 Morgan Stanley
Bristol-Myers' approval of Opdualag as expected, says Morgan Stanley
03/16/22 Canaccord
Nektar price target lowered to $6 from $25 at Canaccord
03/14/22 Cowen
Cowen downgrades Nektar, sees 'high likelihood' of bempeg failure in other uses
03/14/22 Stifel
Nektar downgraded to Hold at Stifel after phase 3 study of bempeg combo fails
RCEL Avita Medical
$7.82 /

+0.26 (+3.44%)

03/01/22 BTIG
Avita Medical price target lowered to $21 from $37 at BTIG
03/01/22 Piper Sandler
Avita Medical price target lowered to $15 from $23 at Piper Sandler
08/27/21 Piper Sandler
Investors should build positions in Avita Medical, says Piper Sandler
06/16/21 Piper Sandler
Avita Medical Q4 results show demand is growing, says Piper Sandler
REGN Regeneron
$693.83 /

+14.29 (+2.10%)

02/23/22 H.C. Wainwright
H.C. Wainwright says Kodiak failure narrows list of rivals for Regeneron's Eylea
02/23/22 Piper Sandler
Regeneron competitor fails to show non-inferiority to Eylea, says Piper Sandler
02/11/22 H.C. Wainwright
Regeneron's Eylea data 'turns up heat' in wet AMD fight, says H.C. Wainwright
02/11/22 Goldman Sachs
Kodiak Sciences initiated with a Buy at Goldman Sachs
SNY Sanofi
$51.84 /

+0.3 (+0.58%)

03/28/22 Morgan Stanley
Sanofi price target raised to EUR 110 from EUR 108 at Morgan Stanley
03/25/22 Credit Suisse
Sanofi price target raised to EUR 105 from EUR 96 at Credit Suisse
03/25/22 Deutsche Bank
Sanofi price target raised to EUR 85 from EUR 80 at Deutsche Bank
03/14/22 Stifel
Arvinas lower after analogous Sanofi drug fails, says Stifel
SSKN Strata Skin Sciences
$1.54 /

-0.1 (-6.10%)

VERO Venus Concept
$1.42 /

+0.055 (+4.03%)

11/12/21 Stifel
Venus Concept price target trimmed to $2 at Stifel after Q3 miss
ASLN Aslan Pharmaceuticals
/

+

09/27/21 Piper Sandler
Piper buyers on Aslan weakness, thinks ASLAN-004 can be competitive
07/09/21 Jefferies
Aslan Pharmaceuticals initiated with a Buy at Jefferies
05/11/21 Piper Sandler
Aslan Pharmaceuticals price target lowered to $8 from $9 at Piper Sandler
CARA Cara Therapeutics
$12.35 /

+0.025 (+0.20%)

03/14/22 Canaccord
Cara Therapeutics price target lowered to $29 from $33 at Canaccord
03/08/22 JPMorgan
Cara Therapeutics upgraded to Overweight from Neutral at JPMorgan
11/01/21 Canaccord
Cara Therapeutics assumed with a Buy at Canaccord
09/28/21 Piper Sandler
Piper Sandler nephrologist survey encouraging for Cara Therapeutics
KRYS Krystal Biotech
$65.66 /

+1.34 (+2.08%)

02/28/22 H.C. Wainwright
Krystal Biotech price target lowered to $107 from $124 at H.C. Wainwright
01/18/22 BofA
Krystal Biotech initiated with a Buy at BofA
01/18/22 BofA
Krystal Biotech initiated with a Buy at BofA
11/29/21 H.C. Wainwright
Krystal Biotech price target raised to $124 from $103 at H.C. Wainwright
IFRX InflaRx
$2.30 /

-0.215 (-8.55%)

02/28/22 Guggenheim
InflaRx cut to Neutral at Guggenheim after 'complete surprise' from FDA
02/28/22 Guggenheim
InflaRx downgraded to Neutral from Buy at Guggenheim
11/15/21 Raymond James
InflaRx's ANCA vasculitis data 'solid,' says Raymond James
10/27/21 Raymond James
Raymond James upgrades InflaRx to Strong Buy after updated PG data
IMUX Immunic
$11.39 /

-0.33 (-2.82%)

02/18/22 Piper Sandler
Piper says baseline demographics give Immunic's CALDOSE trial high odds
02/08/22 Piper Sandler
Piper Sandler more bullish on Immunic ahead of CALDOSE UC study readout
11/19/21 Roth Capital
Roth Capital 'very bullish' on Immunic's IMU-838 in multiple sclerosis
10/27/21 Piper Sandler
Piper says Immunic shares remain undervalued given non-MS pipeline
INCY Incyte
$78.93 /

+0.46 (+0.59%)

02/09/22 SVB Securities
SVB Leerink downgrades Incyte to Underperform, lowers price target to $56
02/09/22 SVB Securities
Incyte downgraded to Underperform from Market Perform at SVB Leerink
01/18/22 RBC Capital
Incyte upgraded to Outperform at RBC Capital on improving 2022 setup
01/18/22 RBC Capital
Incyte upgraded to Outperform from Sector Perform at RBC Capital
BHC Bausch Health
$22.58 /

-0.24 (-1.05%)

02/01/22 RBC Capital
Bausch Health price target lowered to $34 from $40 at RBC Capital
11/03/21 JPMorgan
Bausch Health earnings selloff a buying opportunity, says JPMorgan
09/21/21 JPMorgan
Bausch has 50% upside based on sum-of-the-parts, says JPMorgan
08/04/21 JPMorgan
Bausch Health selloff on Solta IPO plans overdone, says JPMorgan
VERO Venus Concept
$1.42 /

+0.055 (+4.03%)

SSKN Strata Skin Sciences
$1.54 /

-0.1 (-6.10%)

SNY Sanofi
$51.84 /

+0.3 (+0.58%)

REGN Regeneron
$693.83 /

+14.29 (+2.10%)

RCEL Avita Medical
$7.82 /

+0.26 (+3.44%)

KRYS Krystal Biotech
$65.66 /

+1.34 (+2.08%)

INCY Incyte
$78.93 /

+0.46 (+0.59%)

IMUX Immunic
$11.39 /

-0.33 (-2.82%)

IFRX InflaRx
$2.30 /

-0.215 (-8.55%)

CARA Cara Therapeutics
$12.35 /

+0.025 (+0.20%)

BMY Bristol-Myers
$73.13 /

-0.16 (-0.22%)

BHC Bausch Health
$22.58 /

-0.24 (-1.05%)

BBI Brickell Biotech
/

+

ASLN Aslan Pharmaceuticals
/

+

AMYT Amryt Pharma
$8.13 /

-0.17 (-2.05%)

AMGN Amgen
$240.34 /

+1.56 (+0.65%)

ABBV AbbVie
$161.95 /

+0.61 (+0.38%)

  • 01
    Dec
  • 28
    Oct
  • 15
    Jul
SNY Sanofi
$51.84 /

+0.3 (+0.58%)

REGN Regeneron
$693.83 /

+14.29 (+2.10%)

BMY Bristol-Myers
$73.13 /

-0.16 (-0.22%)

AMGN Amgen
$240.34 /

+1.56 (+0.65%)

ABBV AbbVie
$161.95 /

+0.61 (+0.38%)

VERO Venus Concept
$1.42 /

+0.055 (+4.03%)

SNY Sanofi
$51.84 /

+0.3 (+0.58%)

REGN Regeneron
$693.83 /

+14.29 (+2.10%)

KRYS Krystal Biotech
$65.66 /

+1.34 (+2.08%)

INCY Incyte
$78.93 /

+0.46 (+0.59%)

BMY Bristol-Myers
$73.13 /

-0.16 (-0.22%)

BHC Bausch Health
$22.58 /

-0.24 (-1.05%)

BBI Brickell Biotech
/

+

AMYT Amryt Pharma
$8.13 /

-0.17 (-2.05%)

AMGN Amgen
$240.34 /

+1.56 (+0.65%)

ABBV AbbVie
$161.95 /

+0.61 (+0.38%)

INCY Incyte
$78.93 /

+0.46 (+0.59%)

IFRX InflaRx
$2.30 /

-0.215 (-8.55%)

BMY Bristol-Myers
$73.13 /

-0.16 (-0.22%)

BHC Bausch Health
$22.58 /

-0.24 (-1.05%)

AMGN Amgen
$240.34 /

+1.56 (+0.65%)

ABBV AbbVie
$161.95 /

+0.61 (+0.38%)

Conference/Events
American Academy of Dermatology to hold annual meeting » 04:55
03/28/22
03/28
04:55
03/28/22
04:55
ABBV

AbbVie

$161.34 /

+1.08 (+0.67%)

, AMGN

Amgen

$238.75 /

+1.9 (+0.80%)

, AMYT

Amryt Pharma

$8.30 /

+0.03 (+0.36%)

, BBI

Brickell Biotech

/

+

, BMY

Bristol-Myers

$73.28 /

+0.86 (+1.19%)

, RCEL

Avita Medical

$7.55 /

-0.305 (-3.88%)

, REGN

Regeneron

$680.00 /

+0.57 (+0.08%)

, SNY

Sanofi

$51.51 /

+0.305 (+0.60%)

, SSKN

Strata Skin Sciences

$1.64 /

-0.01 (-0.61%)

, VERO

Venus Concept

$1.39 /

-0.005 (-0.36%)

, ASLN

Aslan Pharmaceuticals

/

+

, CARA

Cara Therapeutics

$12.33 /

+0.025 (+0.20%)

, KRYS

Krystal Biotech

$64.19 /

-1.4 (-2.13%)

, IFRX

InflaRx

$2.52 /

+0.035 (+1.41%)

, IMUX

Immunic

$11.76 /

-0.11 (-0.93%)

, INCY

Incyte

$78.47 /

+0.235 (+0.30%)

, BHC

Bausch Health

$22.81 /

-0.59 (-2.52%)

2022 AAD Annual Meeting…

2022 AAD Annual Meeting to be held in Boston on March 25-29.

ShowHide Related Items >><<
VERO Venus Concept
$1.39 /

-0.005 (-0.36%)

SSKN Strata Skin Sciences
$1.64 /

-0.01 (-0.61%)

SNY Sanofi
$51.51 /

+0.305 (+0.60%)

REGN Regeneron
$680.00 /

+0.57 (+0.08%)

RCEL Avita Medical
$7.55 /

-0.305 (-3.88%)

KRYS Krystal Biotech
$64.19 /

-1.4 (-2.13%)

INCY Incyte
$78.47 /

+0.235 (+0.30%)

IMUX Immunic
$11.76 /

-0.11 (-0.93%)

IFRX InflaRx
$2.52 /

+0.035 (+1.41%)

CARA Cara Therapeutics
$12.33 /

+0.025 (+0.20%)

BMY Bristol-Myers
$73.28 /

+0.86 (+1.19%)

BHC Bausch Health
$22.81 /

-0.59 (-2.52%)

BBI Brickell Biotech
/

+

ASLN Aslan Pharmaceuticals
/

+

AMYT Amryt Pharma
$8.30 /

+0.03 (+0.36%)

AMGN Amgen
$238.75 /

+1.9 (+0.80%)

ABBV AbbVie
$161.34 /

+1.08 (+0.67%)

ABBV AbbVie
$161.34 /

+1.08 (+0.67%)

03/22/22 Jefferies
Vertex 'the cleanest story in large-cap biotech,' says Jefferies
03/21/22 Northland
Oaktree Acquisition Corp. II initiated with an Outperform at Northland
03/01/22 Citi
AbbVie price target raised to $170 from $155 at Citi
02/28/22 BMO Capital
Morphic price target lowered to $83 from $102 at BMO Capital
AMGN Amgen
$238.75 /

+1.9 (+0.80%)

03/22/22 Mizuho
Puerto Rico tax change could raise Amgen tax rate in 2023, says Mizuho
03/02/22 Citi
Mirati Therapeutics price target lowered to $227 from $244 at Citi
03/01/22 Mizuho
Amgen price target raised to $202 from $194 at Mizuho
03/01/22 Stifel
Stifel upgrades Revolution Medicines, sees good entry point after pullback
AMYT Amryt Pharma
$8.30 /

+0.03 (+0.36%)

03/10/22 H.C. Wainwright
Amryt Pharma price target lowered to $18 from $20 at H.C. Wainwright
03/01/22 Maxim
Amryt Pharma price target lowered to $18 from $27 at Maxim
03/01/22 Canaccord
Amryt Pharma price target lowered to $19 from $40 at Canaccord
03/01/22 H.C. Wainwright
Amryt Pharma price target lowered to $20 from $29 at H.C. Wainwright
BBI Brickell Biotech
/

+

03/08/22 William Blair
Brickell Biotech initiated with an Outperform at William Blair
01/18/22 H.C. Wainwright
Brickell Biotech initiated with a Buy at H.C. Wainwright
09/01/21 Lake Street
Brickell license deal brings 'multiple new value-drivers,' says Lake Street
04/26/21 Lake Street
Brickell Biotech Phase 3 safety results build confidence, says Lake Street
BMY Bristol-Myers
$73.28 /

+0.86 (+1.19%)

03/21/22 Morgan Stanley
Bristol-Myers' approval of Opdualag as expected, says Morgan Stanley
03/16/22 Canaccord
Nektar price target lowered to $6 from $25 at Canaccord
03/14/22 Cowen
Cowen downgrades Nektar, sees 'high likelihood' of bempeg failure in other uses
03/14/22 Stifel
Nektar downgraded to Hold at Stifel after phase 3 study of bempeg combo fails
RCEL Avita Medical
$7.55 /

-0.305 (-3.88%)

03/01/22 BTIG
Avita Medical price target lowered to $21 from $37 at BTIG
03/01/22 Piper Sandler
Avita Medical price target lowered to $15 from $23 at Piper Sandler
08/27/21 Piper Sandler
Investors should build positions in Avita Medical, says Piper Sandler
06/16/21 Piper Sandler
Avita Medical Q4 results show demand is growing, says Piper Sandler
REGN Regeneron
$680.00 /

+0.57 (+0.08%)

02/23/22 H.C. Wainwright
H.C. Wainwright says Kodiak failure narrows list of rivals for Regeneron's Eylea
02/23/22 Piper Sandler
Regeneron competitor fails to show non-inferiority to Eylea, says Piper Sandler
02/11/22 H.C. Wainwright
Regeneron's Eylea data 'turns up heat' in wet AMD fight, says H.C. Wainwright
02/11/22 Goldman Sachs
Kodiak Sciences initiated with a Buy at Goldman Sachs
SNY Sanofi
$51.51 /

+0.305 (+0.60%)

03/25/22 Credit Suisse
Sanofi price target raised to EUR 105 from EUR 96 at Credit Suisse
03/25/22 Deutsche Bank
Sanofi price target raised to EUR 85 from EUR 80 at Deutsche Bank
03/14/22 Stifel
Arvinas lower after analogous Sanofi drug fails, says Stifel
03/02/22 Alliance Global Partners
DarioHealth pact with Sanofi 'potentially game changing,' says Alliance Global
SSKN Strata Skin Sciences
$1.64 /

-0.01 (-0.61%)

VERO Venus Concept
$1.39 /

-0.005 (-0.36%)

11/12/21 Stifel
Venus Concept price target trimmed to $2 at Stifel after Q3 miss
ASLN Aslan Pharmaceuticals
/

+

09/27/21 Piper Sandler
Piper buyers on Aslan weakness, thinks ASLAN-004 can be competitive
07/09/21 Jefferies
Aslan Pharmaceuticals initiated with a Buy at Jefferies
05/11/21 Piper Sandler
Aslan Pharmaceuticals price target lowered to $8 from $9 at Piper Sandler
CARA Cara Therapeutics
$12.33 /

+0.025 (+0.20%)

03/14/22 Canaccord
Cara Therapeutics price target lowered to $29 from $33 at Canaccord
03/08/22 JPMorgan
Cara Therapeutics upgraded to Overweight from Neutral at JPMorgan
11/01/21 Canaccord
Cara Therapeutics assumed with a Buy at Canaccord
09/28/21 Piper Sandler
Piper Sandler nephrologist survey encouraging for Cara Therapeutics
KRYS Krystal Biotech
$64.19 /

-1.4 (-2.13%)

02/28/22 H.C. Wainwright
Krystal Biotech price target lowered to $107 from $124 at H.C. Wainwright
01/18/22 BofA
Krystal Biotech initiated with a Buy at BofA
01/18/22 BofA
Krystal Biotech initiated with a Buy at BofA
11/29/21 H.C. Wainwright
Krystal Biotech price target raised to $124 from $103 at H.C. Wainwright
IFRX InflaRx
$2.52 /

+0.035 (+1.41%)

02/28/22 Guggenheim
InflaRx cut to Neutral at Guggenheim after 'complete surprise' from FDA
02/28/22 Guggenheim
InflaRx downgraded to Neutral from Buy at Guggenheim
11/15/21 Raymond James
InflaRx's ANCA vasculitis data 'solid,' says Raymond James
10/27/21 Raymond James
Raymond James upgrades InflaRx to Strong Buy after updated PG data
IMUX Immunic
$11.76 /

-0.11 (-0.93%)

02/18/22 Piper Sandler
Piper says baseline demographics give Immunic's CALDOSE trial high odds
02/08/22 Piper Sandler
Piper Sandler more bullish on Immunic ahead of CALDOSE UC study readout
11/19/21 Roth Capital
Roth Capital 'very bullish' on Immunic's IMU-838 in multiple sclerosis
10/27/21 Piper Sandler
Piper says Immunic shares remain undervalued given non-MS pipeline
INCY Incyte
$78.47 /

+0.235 (+0.30%)

02/09/22 SVB Securities
SVB Leerink downgrades Incyte to Underperform, lowers price target to $56
02/09/22 SVB Securities
Incyte downgraded to Underperform from Market Perform at SVB Leerink
01/18/22 RBC Capital
Incyte upgraded to Outperform at RBC Capital on improving 2022 setup
01/18/22 RBC Capital
Incyte upgraded to Outperform from Sector Perform at RBC Capital
BHC Bausch Health
$22.81 /

-0.59 (-2.52%)

02/01/22 RBC Capital
Bausch Health price target lowered to $34 from $40 at RBC Capital
11/03/21 JPMorgan
Bausch Health earnings selloff a buying opportunity, says JPMorgan
09/21/21 JPMorgan
Bausch has 50% upside based on sum-of-the-parts, says JPMorgan
08/04/21 JPMorgan
Bausch Health selloff on Solta IPO plans overdone, says JPMorgan
VERO Venus Concept
$1.39 /

-0.005 (-0.36%)

SSKN Strata Skin Sciences
$1.64 /

-0.01 (-0.61%)

SNY Sanofi
$51.51 /

+0.305 (+0.60%)

REGN Regeneron
$680.00 /

+0.57 (+0.08%)

RCEL Avita Medical
$7.55 /

-0.305 (-3.88%)

KRYS Krystal Biotech
$64.19 /

-1.4 (-2.13%)

INCY Incyte
$78.47 /

+0.235 (+0.30%)

IMUX Immunic
$11.76 /

-0.11 (-0.93%)

IFRX InflaRx
$2.52 /

+0.035 (+1.41%)

CARA Cara Therapeutics
$12.33 /

+0.025 (+0.20%)

BMY Bristol-Myers
$73.28 /

+0.86 (+1.19%)

BHC Bausch Health
$22.81 /

-0.59 (-2.52%)

BBI Brickell Biotech
/

+

ASLN Aslan Pharmaceuticals
/

+

AMYT Amryt Pharma
$8.30 /

+0.03 (+0.36%)

AMGN Amgen
$238.75 /

+1.9 (+0.80%)

ABBV AbbVie
$161.34 /

+1.08 (+0.67%)

  • 01
    Dec
  • 28
    Oct
  • 15
    Jul
SNY Sanofi
$51.51 /

+0.305 (+0.60%)

REGN Regeneron
$680.00 /

+0.57 (+0.08%)

BMY Bristol-Myers
$73.28 /

+0.86 (+1.19%)

AMGN Amgen
$238.75 /

+1.9 (+0.80%)

ABBV AbbVie
$161.34 /

+1.08 (+0.67%)

VERO Venus Concept
$1.39 /

-0.005 (-0.36%)

SNY Sanofi
$51.51 /

+0.305 (+0.60%)

REGN Regeneron
$680.00 /

+0.57 (+0.08%)

KRYS Krystal Biotech
$64.19 /

-1.4 (-2.13%)

INCY Incyte
$78.47 /

+0.235 (+0.30%)

BMY Bristol-Myers
$73.28 /

+0.86 (+1.19%)

BHC Bausch Health
$22.81 /

-0.59 (-2.52%)

BBI Brickell Biotech
/

+

AMYT Amryt Pharma
$8.30 /

+0.03 (+0.36%)

AMGN Amgen
$238.75 /

+1.9 (+0.80%)

ABBV AbbVie
$161.34 /

+1.08 (+0.67%)

INCY Incyte
$78.47 /

+0.235 (+0.30%)

IFRX InflaRx
$2.52 /

+0.035 (+1.41%)

BMY Bristol-Myers
$73.28 /

+0.86 (+1.19%)

BHC Bausch Health
$22.81 /

-0.59 (-2.52%)

AMGN Amgen
$238.75 /

+1.9 (+0.80%)

ABBV AbbVie
$161.34 /

+1.08 (+0.67%)

Conference/Events
American Academy of Dermatology to hold annual meeting » 04:55
03/27/22
03/27
04:55
03/27/22
04:55
ABBV

AbbVie

$161.34 /

+1.08 (+0.67%)

, AMGN

Amgen

$238.75 /

+1.9 (+0.80%)

, AMYT

Amryt Pharma

$8.30 /

+0.03 (+0.36%)

, BBI

Brickell Biotech

/

+

, BMY

Bristol-Myers

$73.28 /

+0.86 (+1.19%)

, RCEL

Avita Medical

$7.55 /

-0.305 (-3.88%)

, REGN

Regeneron

$680.00 /

+0.57 (+0.08%)

, SNY

Sanofi

$51.51 /

+0.305 (+0.60%)

, SSKN

Strata Skin Sciences

$1.64 /

-0.01 (-0.61%)

, VERO

Venus Concept

$1.39 /

-0.005 (-0.36%)

, ASLN

Aslan Pharmaceuticals

/

+

, CARA

Cara Therapeutics

$12.33 /

+0.025 (+0.20%)

, KRYS

Krystal Biotech

$64.19 /

-1.4 (-2.13%)

, IFRX

InflaRx

$2.52 /

+0.035 (+1.41%)

, IMUX

Immunic

$11.76 /

-0.11 (-0.93%)

, INCY

Incyte

$78.47 /

+0.235 (+0.30%)

, BHC

Bausch Health

$22.81 /

-0.59 (-2.52%)

2022 AAD Annual Meeting…

2022 AAD Annual Meeting to be held in Boston on March 25-29.

ShowHide Related Items >><<
VERO Venus Concept
$1.39 /

-0.005 (-0.36%)

SSKN Strata Skin Sciences
$1.64 /

-0.01 (-0.61%)

SNY Sanofi
$51.51 /

+0.305 (+0.60%)

REGN Regeneron
$680.00 /

+0.57 (+0.08%)

RCEL Avita Medical
$7.55 /

-0.305 (-3.88%)

KRYS Krystal Biotech
$64.19 /

-1.4 (-2.13%)

INCY Incyte
$78.47 /

+0.235 (+0.30%)

IMUX Immunic
$11.76 /

-0.11 (-0.93%)

IFRX InflaRx
$2.52 /

+0.035 (+1.41%)

CARA Cara Therapeutics
$12.33 /

+0.025 (+0.20%)

BMY Bristol-Myers
$73.28 /

+0.86 (+1.19%)

BHC Bausch Health
$22.81 /

-0.59 (-2.52%)

BBI Brickell Biotech
/

+

ASLN Aslan Pharmaceuticals
/

+

AMYT Amryt Pharma
$8.30 /

+0.03 (+0.36%)

AMGN Amgen
$238.75 /

+1.9 (+0.80%)

ABBV AbbVie
$161.34 /

+1.08 (+0.67%)

ABBV AbbVie
$161.34 /

+1.08 (+0.67%)

03/22/22 Jefferies
Vertex 'the cleanest story in large-cap biotech,' says Jefferies
03/21/22 Northland
Oaktree Acquisition Corp. II initiated with an Outperform at Northland
03/01/22 Citi
AbbVie price target raised to $170 from $155 at Citi
02/28/22 BMO Capital
Morphic price target lowered to $83 from $102 at BMO Capital
AMGN Amgen
$238.75 /

+1.9 (+0.80%)

03/22/22 Mizuho
Puerto Rico tax change could raise Amgen tax rate in 2023, says Mizuho
03/02/22 Citi
Mirati Therapeutics price target lowered to $227 from $244 at Citi
03/01/22 Mizuho
Amgen price target raised to $202 from $194 at Mizuho
03/01/22 Stifel
Stifel upgrades Revolution Medicines, sees good entry point after pullback
AMYT Amryt Pharma
$8.30 /

+0.03 (+0.36%)

03/10/22 H.C. Wainwright
Amryt Pharma price target lowered to $18 from $20 at H.C. Wainwright
03/01/22 Maxim
Amryt Pharma price target lowered to $18 from $27 at Maxim
03/01/22 Canaccord
Amryt Pharma price target lowered to $19 from $40 at Canaccord
03/01/22 H.C. Wainwright
Amryt Pharma price target lowered to $20 from $29 at H.C. Wainwright
BBI Brickell Biotech
/

+

03/08/22 William Blair
Brickell Biotech initiated with an Outperform at William Blair
01/18/22 H.C. Wainwright
Brickell Biotech initiated with a Buy at H.C. Wainwright
09/01/21 Lake Street
Brickell license deal brings 'multiple new value-drivers,' says Lake Street
04/26/21 Lake Street
Brickell Biotech Phase 3 safety results build confidence, says Lake Street
BMY Bristol-Myers
$73.28 /

+0.86 (+1.19%)

03/21/22 Morgan Stanley
Bristol-Myers' approval of Opdualag as expected, says Morgan Stanley
03/16/22 Canaccord
Nektar price target lowered to $6 from $25 at Canaccord
03/14/22 Cowen
Cowen downgrades Nektar, sees 'high likelihood' of bempeg failure in other uses
03/14/22 Stifel
Nektar downgraded to Hold at Stifel after phase 3 study of bempeg combo fails
RCEL Avita Medical
$7.55 /

-0.305 (-3.88%)

03/01/22 BTIG
Avita Medical price target lowered to $21 from $37 at BTIG
03/01/22 Piper Sandler
Avita Medical price target lowered to $15 from $23 at Piper Sandler
08/27/21 Piper Sandler
Investors should build positions in Avita Medical, says Piper Sandler
06/16/21 Piper Sandler
Avita Medical Q4 results show demand is growing, says Piper Sandler
REGN Regeneron
$680.00 /

+0.57 (+0.08%)

02/23/22 H.C. Wainwright
H.C. Wainwright says Kodiak failure narrows list of rivals for Regeneron's Eylea
02/23/22 Piper Sandler
Regeneron competitor fails to show non-inferiority to Eylea, says Piper Sandler
02/11/22 H.C. Wainwright
Regeneron's Eylea data 'turns up heat' in wet AMD fight, says H.C. Wainwright
02/11/22 Goldman Sachs
Kodiak Sciences initiated with a Buy at Goldman Sachs
SNY Sanofi
$51.51 /

+0.305 (+0.60%)

03/25/22 Credit Suisse
Sanofi price target raised to EUR 105 from EUR 96 at Credit Suisse
03/25/22 Deutsche Bank
Sanofi price target raised to EUR 85 from EUR 80 at Deutsche Bank
03/14/22 Stifel
Arvinas lower after analogous Sanofi drug fails, says Stifel
03/02/22 Alliance Global Partners
DarioHealth pact with Sanofi 'potentially game changing,' says Alliance Global
SSKN Strata Skin Sciences
$1.64 /

-0.01 (-0.61%)

VERO Venus Concept
$1.39 /

-0.005 (-0.36%)

11/12/21 Stifel
Venus Concept price target trimmed to $2 at Stifel after Q3 miss
ASLN Aslan Pharmaceuticals
/

+

09/27/21 Piper Sandler
Piper buyers on Aslan weakness, thinks ASLAN-004 can be competitive
07/09/21 Jefferies
Aslan Pharmaceuticals initiated with a Buy at Jefferies
05/11/21 Piper Sandler
Aslan Pharmaceuticals price target lowered to $8 from $9 at Piper Sandler
CARA Cara Therapeutics
$12.33 /

+0.025 (+0.20%)

03/14/22 Canaccord
Cara Therapeutics price target lowered to $29 from $33 at Canaccord
03/08/22 JPMorgan
Cara Therapeutics upgraded to Overweight from Neutral at JPMorgan
11/01/21 Canaccord
Cara Therapeutics assumed with a Buy at Canaccord
09/28/21 Piper Sandler
Piper Sandler nephrologist survey encouraging for Cara Therapeutics
KRYS Krystal Biotech
$64.19 /

-1.4 (-2.13%)

02/28/22 H.C. Wainwright
Krystal Biotech price target lowered to $107 from $124 at H.C. Wainwright
01/18/22 BofA
Krystal Biotech initiated with a Buy at BofA
01/18/22 BofA
Krystal Biotech initiated with a Buy at BofA
11/29/21 H.C. Wainwright
Krystal Biotech price target raised to $124 from $103 at H.C. Wainwright
IFRX InflaRx
$2.52 /

+0.035 (+1.41%)

02/28/22 Guggenheim
InflaRx cut to Neutral at Guggenheim after 'complete surprise' from FDA
02/28/22 Guggenheim
InflaRx downgraded to Neutral from Buy at Guggenheim
11/15/21 Raymond James
InflaRx's ANCA vasculitis data 'solid,' says Raymond James
10/27/21 Raymond James
Raymond James upgrades InflaRx to Strong Buy after updated PG data
IMUX Immunic
$11.76 /

-0.11 (-0.93%)

02/18/22 Piper Sandler
Piper says baseline demographics give Immunic's CALDOSE trial high odds
02/08/22 Piper Sandler
Piper Sandler more bullish on Immunic ahead of CALDOSE UC study readout
11/19/21 Roth Capital
Roth Capital 'very bullish' on Immunic's IMU-838 in multiple sclerosis
10/27/21 Piper Sandler
Piper says Immunic shares remain undervalued given non-MS pipeline
INCY Incyte
$78.47 /

+0.235 (+0.30%)

02/09/22 SVB Securities
SVB Leerink downgrades Incyte to Underperform, lowers price target to $56
02/09/22 SVB Securities
Incyte downgraded to Underperform from Market Perform at SVB Leerink
01/18/22 RBC Capital
Incyte upgraded to Outperform at RBC Capital on improving 2022 setup
01/18/22 RBC Capital
Incyte upgraded to Outperform from Sector Perform at RBC Capital
BHC Bausch Health
$22.81 /

-0.59 (-2.52%)

02/01/22 RBC Capital
Bausch Health price target lowered to $34 from $40 at RBC Capital
11/03/21 JPMorgan
Bausch Health earnings selloff a buying opportunity, says JPMorgan
09/21/21 JPMorgan
Bausch has 50% upside based on sum-of-the-parts, says JPMorgan
08/04/21 JPMorgan
Bausch Health selloff on Solta IPO plans overdone, says JPMorgan
VERO Venus Concept
$1.39 /

-0.005 (-0.36%)

SSKN Strata Skin Sciences
$1.64 /

-0.01 (-0.61%)

SNY Sanofi
$51.51 /

+0.305 (+0.60%)

REGN Regeneron
$680.00 /

+0.57 (+0.08%)

RCEL Avita Medical
$7.55 /

-0.305 (-3.88%)

KRYS Krystal Biotech
$64.19 /

-1.4 (-2.13%)

INCY Incyte
$78.47 /

+0.235 (+0.30%)

IMUX Immunic
$11.76 /

-0.11 (-0.93%)

IFRX InflaRx
$2.52 /

+0.035 (+1.41%)

CARA Cara Therapeutics
$12.33 /

+0.025 (+0.20%)

BMY Bristol-Myers
$73.28 /

+0.86 (+1.19%)

BHC Bausch Health
$22.81 /

-0.59 (-2.52%)

BBI Brickell Biotech
/

+

ASLN Aslan Pharmaceuticals
/

+

AMYT Amryt Pharma
$8.30 /

+0.03 (+0.36%)

AMGN Amgen
$238.75 /

+1.9 (+0.80%)

ABBV AbbVie
$161.34 /

+1.08 (+0.67%)

  • 01
    Dec
  • 28
    Oct
  • 15
    Jul
SNY Sanofi
$51.51 /

+0.305 (+0.60%)

REGN Regeneron
$680.00 /

+0.57 (+0.08%)

BMY Bristol-Myers
$73.28 /

+0.86 (+1.19%)

AMGN Amgen
$238.75 /

+1.9 (+0.80%)

ABBV AbbVie
$161.34 /

+1.08 (+0.67%)

VERO Venus Concept
$1.39 /

-0.005 (-0.36%)

SNY Sanofi
$51.51 /

+0.305 (+0.60%)

REGN Regeneron
$680.00 /

+0.57 (+0.08%)

KRYS Krystal Biotech
$64.19 /

-1.4 (-2.13%)

INCY Incyte
$78.47 /

+0.235 (+0.30%)

BMY Bristol-Myers
$73.28 /

+0.86 (+1.19%)

BHC Bausch Health
$22.81 /

-0.59 (-2.52%)

BBI Brickell Biotech
/

+

ASLN Aslan Pharmaceuticals
/

+

AMYT Amryt Pharma
$8.30 /

+0.03 (+0.36%)

AMGN Amgen
$238.75 /

+1.9 (+0.80%)

ABBV AbbVie
$161.34 /

+1.08 (+0.67%)

INCY Incyte
$78.47 /

+0.235 (+0.30%)

IFRX InflaRx
$2.52 /

+0.035 (+1.41%)

BMY Bristol-Myers
$73.28 /

+0.86 (+1.19%)

BHC Bausch Health
$22.81 /

-0.59 (-2.52%)

AMGN Amgen
$238.75 /

+1.9 (+0.80%)

ABBV AbbVie
$161.34 /

+1.08 (+0.67%)

Conference/Events
American Academy of Dermatology to hold annual meeting » 04:55
03/26/22
03/26
04:55
03/26/22
04:55
ABBV

AbbVie

$161.34 /

+1.08 (+0.67%)

, AMGN

Amgen

$238.75 /

+1.9 (+0.80%)

, AMYT

Amryt Pharma

$8.30 /

+0.03 (+0.36%)

, BBI

Brickell Biotech

/

+

, BMY

Bristol-Myers

$73.28 /

+0.86 (+1.19%)

, RCEL

Avita Medical

$7.55 /

-0.305 (-3.88%)

, REGN

Regeneron

$680.00 /

+0.57 (+0.08%)

, SNY

Sanofi

$51.51 /

+0.305 (+0.60%)

, SSKN

Strata Skin Sciences

$1.64 /

-0.01 (-0.61%)

, VERO

Venus Concept

$1.39 /

-0.005 (-0.36%)

, ASLN

Aslan Pharmaceuticals

/

+

, CARA

Cara Therapeutics

$12.33 /

+0.025 (+0.20%)

, KRYS

Krystal Biotech

$64.19 /

-1.4 (-2.13%)

, IFRX

InflaRx

$2.52 /

+0.035 (+1.41%)

, IMUX

Immunic

$11.76 /

-0.11 (-0.93%)

, INCY

Incyte

$78.47 /

+0.235 (+0.30%)

, BHC

Bausch Health

$22.81 /

-0.59 (-2.52%)

2022 AAD Annual Meeting…

2022 AAD Annual Meeting to be held in Boston on March 25-29.

ShowHide Related Items >><<
VERO Venus Concept
$1.39 /

-0.005 (-0.36%)

SSKN Strata Skin Sciences
$1.64 /

-0.01 (-0.61%)

SNY Sanofi
$51.51 /

+0.305 (+0.60%)

REGN Regeneron
$680.00 /

+0.57 (+0.08%)

RCEL Avita Medical
$7.55 /

-0.305 (-3.88%)

KRYS Krystal Biotech
$64.19 /

-1.4 (-2.13%)

INCY Incyte
$78.47 /

+0.235 (+0.30%)

IMUX Immunic
$11.76 /

-0.11 (-0.93%)

IFRX InflaRx
$2.52 /

+0.035 (+1.41%)

CARA Cara Therapeutics
$12.33 /

+0.025 (+0.20%)

BMY Bristol-Myers
$73.28 /

+0.86 (+1.19%)

BHC Bausch Health
$22.81 /

-0.59 (-2.52%)

BBI Brickell Biotech
/

+

ASLN Aslan Pharmaceuticals
/

+

AMYT Amryt Pharma
$8.30 /

+0.03 (+0.36%)

AMGN Amgen
$238.75 /

+1.9 (+0.80%)

ABBV AbbVie
$161.34 /

+1.08 (+0.67%)

ABBV AbbVie
$161.34 /

+1.08 (+0.67%)

03/22/22 Jefferies
Vertex 'the cleanest story in large-cap biotech,' says Jefferies
03/21/22 Northland
Oaktree Acquisition Corp. II initiated with an Outperform at Northland
03/01/22 Citi
AbbVie price target raised to $170 from $155 at Citi
02/28/22 BMO Capital
Morphic price target lowered to $83 from $102 at BMO Capital
AMGN Amgen
$238.75 /

+1.9 (+0.80%)

03/22/22 Mizuho
Puerto Rico tax change could raise Amgen tax rate in 2023, says Mizuho
03/02/22 Citi
Mirati Therapeutics price target lowered to $227 from $244 at Citi
03/01/22 Mizuho
Amgen price target raised to $202 from $194 at Mizuho
03/01/22 Stifel
Stifel upgrades Revolution Medicines, sees good entry point after pullback
AMYT Amryt Pharma
$8.30 /

+0.03 (+0.36%)

03/10/22 H.C. Wainwright
Amryt Pharma price target lowered to $18 from $20 at H.C. Wainwright
03/01/22 Maxim
Amryt Pharma price target lowered to $18 from $27 at Maxim
03/01/22 Canaccord
Amryt Pharma price target lowered to $19 from $40 at Canaccord
03/01/22 H.C. Wainwright
Amryt Pharma price target lowered to $20 from $29 at H.C. Wainwright
BBI Brickell Biotech
/

+

03/08/22 William Blair
Brickell Biotech initiated with an Outperform at William Blair
01/18/22 H.C. Wainwright
Brickell Biotech initiated with a Buy at H.C. Wainwright
09/01/21 Lake Street
Brickell license deal brings 'multiple new value-drivers,' says Lake Street
04/26/21 Lake Street
Brickell Biotech Phase 3 safety results build confidence, says Lake Street
BMY Bristol-Myers
$73.28 /

+0.86 (+1.19%)

03/21/22 Morgan Stanley
Bristol-Myers' approval of Opdualag as expected, says Morgan Stanley
03/16/22 Canaccord
Nektar price target lowered to $6 from $25 at Canaccord
03/14/22 Cowen
Cowen downgrades Nektar, sees 'high likelihood' of bempeg failure in other uses
03/14/22 Stifel
Nektar downgraded to Hold at Stifel after phase 3 study of bempeg combo fails
RCEL Avita Medical
$7.55 /

-0.305 (-3.88%)

03/01/22 BTIG
Avita Medical price target lowered to $21 from $37 at BTIG
03/01/22 Piper Sandler
Avita Medical price target lowered to $15 from $23 at Piper Sandler
08/27/21 Piper Sandler
Investors should build positions in Avita Medical, says Piper Sandler
06/16/21 Piper Sandler
Avita Medical Q4 results show demand is growing, says Piper Sandler
REGN Regeneron
$680.00 /

+0.57 (+0.08%)

02/23/22 H.C. Wainwright
H.C. Wainwright says Kodiak failure narrows list of rivals for Regeneron's Eylea
02/23/22 Piper Sandler
Regeneron competitor fails to show non-inferiority to Eylea, says Piper Sandler
02/11/22 H.C. Wainwright
Regeneron's Eylea data 'turns up heat' in wet AMD fight, says H.C. Wainwright
02/11/22 Goldman Sachs
Kodiak Sciences initiated with a Buy at Goldman Sachs
SNY Sanofi
$51.51 /

+0.305 (+0.60%)

03/25/22 Credit Suisse
Sanofi price target raised to EUR 105 from EUR 96 at Credit Suisse
03/25/22 Deutsche Bank
Sanofi price target raised to EUR 85 from EUR 80 at Deutsche Bank
03/14/22 Stifel
Arvinas lower after analogous Sanofi drug fails, says Stifel
03/02/22 Alliance Global Partners
DarioHealth pact with Sanofi 'potentially game changing,' says Alliance Global
SSKN Strata Skin Sciences
$1.64 /

-0.01 (-0.61%)

VERO Venus Concept
$1.39 /

-0.005 (-0.36%)

11/12/21 Stifel
Venus Concept price target trimmed to $2 at Stifel after Q3 miss
ASLN Aslan Pharmaceuticals
/

+

09/27/21 Piper Sandler
Piper buyers on Aslan weakness, thinks ASLAN-004 can be competitive
07/09/21 Jefferies
Aslan Pharmaceuticals initiated with a Buy at Jefferies
05/11/21 Piper Sandler
Aslan Pharmaceuticals price target lowered to $8 from $9 at Piper Sandler
CARA Cara Therapeutics
$12.33 /

+0.025 (+0.20%)

03/14/22 Canaccord
Cara Therapeutics price target lowered to $29 from $33 at Canaccord
03/08/22 JPMorgan
Cara Therapeutics upgraded to Overweight from Neutral at JPMorgan
11/01/21 Canaccord
Cara Therapeutics assumed with a Buy at Canaccord
09/28/21 Piper Sandler
Piper Sandler nephrologist survey encouraging for Cara Therapeutics
KRYS Krystal Biotech
$64.19 /

-1.4 (-2.13%)

02/28/22 H.C. Wainwright
Krystal Biotech price target lowered to $107 from $124 at H.C. Wainwright
01/18/22 BofA
Krystal Biotech initiated with a Buy at BofA
01/18/22 BofA
Krystal Biotech initiated with a Buy at BofA
11/29/21 H.C. Wainwright
Krystal Biotech price target raised to $124 from $103 at H.C. Wainwright
IFRX InflaRx
$2.52 /

+0.035 (+1.41%)

02/28/22 Guggenheim
InflaRx cut to Neutral at Guggenheim after 'complete surprise' from FDA
02/28/22 Guggenheim
InflaRx downgraded to Neutral from Buy at Guggenheim
11/15/21 Raymond James
InflaRx's ANCA vasculitis data 'solid,' says Raymond James
10/27/21 Raymond James
Raymond James upgrades InflaRx to Strong Buy after updated PG data
IMUX Immunic
$11.76 /

-0.11 (-0.93%)

02/18/22 Piper Sandler
Piper says baseline demographics give Immunic's CALDOSE trial high odds
02/08/22 Piper Sandler
Piper Sandler more bullish on Immunic ahead of CALDOSE UC study readout
11/19/21 Roth Capital
Roth Capital 'very bullish' on Immunic's IMU-838 in multiple sclerosis
10/27/21 Piper Sandler
Piper says Immunic shares remain undervalued given non-MS pipeline
INCY Incyte
$78.47 /

+0.235 (+0.30%)

02/09/22 SVB Securities
SVB Leerink downgrades Incyte to Underperform, lowers price target to $56
02/09/22 SVB Securities
Incyte downgraded to Underperform from Market Perform at SVB Leerink
01/18/22 RBC Capital
Incyte upgraded to Outperform at RBC Capital on improving 2022 setup
01/18/22 RBC Capital
Incyte upgraded to Outperform from Sector Perform at RBC Capital
BHC Bausch Health
$22.81 /

-0.59 (-2.52%)

02/01/22 RBC Capital
Bausch Health price target lowered to $34 from $40 at RBC Capital
11/03/21 JPMorgan
Bausch Health earnings selloff a buying opportunity, says JPMorgan
09/21/21 JPMorgan
Bausch has 50% upside based on sum-of-the-parts, says JPMorgan
08/04/21 JPMorgan
Bausch Health selloff on Solta IPO plans overdone, says JPMorgan
VERO Venus Concept
$1.39 /

-0.005 (-0.36%)

SSKN Strata Skin Sciences
$1.64 /

-0.01 (-0.61%)

SNY Sanofi
$51.51 /

+0.305 (+0.60%)

REGN Regeneron
$680.00 /

+0.57 (+0.08%)

RCEL Avita Medical
$7.55 /

-0.305 (-3.88%)

KRYS Krystal Biotech
$64.19 /

-1.4 (-2.13%)

INCY Incyte
$78.47 /

+0.235 (+0.30%)

IMUX Immunic
$11.76 /

-0.11 (-0.93%)

IFRX InflaRx
$2.52 /

+0.035 (+1.41%)

CARA Cara Therapeutics
$12.33 /

+0.025 (+0.20%)

BMY Bristol-Myers
$73.28 /

+0.86 (+1.19%)

BHC Bausch Health
$22.81 /

-0.59 (-2.52%)

BBI Brickell Biotech
/

+

ASLN Aslan Pharmaceuticals
/

+

AMYT Amryt Pharma
$8.30 /

+0.03 (+0.36%)

AMGN Amgen
$238.75 /

+1.9 (+0.80%)

ABBV AbbVie
$161.34 /

+1.08 (+0.67%)

  • 01
    Dec
  • 28
    Oct
  • 15
    Jul
SNY Sanofi
$51.51 /

+0.305 (+0.60%)

REGN Regeneron
$680.00 /

+0.57 (+0.08%)

BMY Bristol-Myers
$73.28 /

+0.86 (+1.19%)

AMGN Amgen
$238.75 /

+1.9 (+0.80%)

ABBV AbbVie
$161.34 /

+1.08 (+0.67%)

VERO Venus Concept
$1.39 /

-0.005 (-0.36%)

SNY Sanofi
$51.51 /

+0.305 (+0.60%)

REGN Regeneron
$680.00 /

+0.57 (+0.08%)

KRYS Krystal Biotech
$64.19 /

-1.4 (-2.13%)

INCY Incyte
$78.47 /

+0.235 (+0.30%)

BMY Bristol-Myers
$73.28 /

+0.86 (+1.19%)

BHC Bausch Health
$22.81 /

-0.59 (-2.52%)

BBI Brickell Biotech
/

+

ASLN Aslan Pharmaceuticals
/

+

AMYT Amryt Pharma
$8.30 /

+0.03 (+0.36%)

AMGN Amgen
$238.75 /

+1.9 (+0.80%)

ABBV AbbVie
$161.34 /

+1.08 (+0.67%)

INCY Incyte
$78.47 /

+0.235 (+0.30%)

IFRX InflaRx
$2.52 /

+0.035 (+1.41%)

BMY Bristol-Myers
$73.28 /

+0.86 (+1.19%)

BHC Bausch Health
$22.81 /

-0.59 (-2.52%)

AMGN Amgen
$238.75 /

+1.9 (+0.80%)

ABBV AbbVie
$161.34 /

+1.08 (+0.67%)

Conference/Events
American Academy of Dermatology to hold annual meeting » 10:49
03/25/22
03/25
10:49
03/25/22
10:49
ABBV

AbbVie

$161.91 /

+1.65 (+1.03%)

, AMGN

Amgen

$239.19 /

+2.34 (+0.99%)

, AMYT

Amryt Pharma

$8.05 /

-0.225 (-2.72%)

, BBI

Brickell Biotech

/

+

, BMY

Bristol-Myers

$73.42 /

+1 (+1.38%)

, RCEL

Avita Medical

$7.67 /

-0.185 (-2.36%)

, REGN

Regeneron

$683.91 /

+4.48 (+0.66%)

, SNY

Sanofi

$51.44 /

+0.235 (+0.46%)

, SSKN

Strata Skin Sciences

$1.70 /

+0.05 (+3.03%)

, VERO

Venus Concept

$1.38 /

-0.015 (-1.08%)

, ASLN

Aslan Pharmaceuticals

/

+

, CARA

Cara Therapeutics

$12.11 /

-0.195 (-1.58%)

, KRYS

Krystal Biotech

$65.98 /

+0.39 (+0.59%)

, IFRX

InflaRx

$2.51 /

+0.03 (+1.21%)

, IMUX

Immunic

$11.71 /

-0.16 (-1.35%)

, INCY

Incyte

$78.34 /

+0.105 (+0.13%)

, BHC

Bausch Health

$23.04 /

-0.365 (-1.56%)

2022 AAD Annual Meeting…

2022 AAD Annual Meeting to be held in Boston on March 25-29.

ShowHide Related Items >><<
VERO Venus Concept
$1.38 /

-0.015 (-1.08%)

SSKN Strata Skin Sciences
$1.70 /

+0.05 (+3.03%)

SNY Sanofi
$51.44 /

+0.235 (+0.46%)

REGN Regeneron
$683.91 /

+4.48 (+0.66%)

RCEL Avita Medical
$7.67 /

-0.185 (-2.36%)

KRYS Krystal Biotech
$65.98 /

+0.39 (+0.59%)

INCY Incyte
$78.34 /

+0.105 (+0.13%)

IMUX Immunic
$11.71 /

-0.16 (-1.35%)

IFRX InflaRx
$2.51 /

+0.03 (+1.21%)

CARA Cara Therapeutics
$12.11 /

-0.195 (-1.58%)

BMY Bristol-Myers
$73.42 /

+1 (+1.38%)

BHC Bausch Health
$23.04 /

-0.365 (-1.56%)

BBI Brickell Biotech
/

+

ASLN Aslan Pharmaceuticals
/

+

AMYT Amryt Pharma
$8.05 /

-0.225 (-2.72%)

AMGN Amgen
$239.19 /

+2.34 (+0.99%)

ABBV AbbVie
$161.91 /

+1.65 (+1.03%)

ABBV AbbVie
$161.91 /

+1.65 (+1.03%)

03/22/22 Jefferies
Vertex 'the cleanest story in large-cap biotech,' says Jefferies
03/21/22 Northland
Oaktree Acquisition Corp. II initiated with an Outperform at Northland
03/01/22 Citi
AbbVie price target raised to $170 from $155 at Citi
02/28/22 BMO Capital
Morphic price target lowered to $83 from $102 at BMO Capital
AMGN Amgen
$239.19 /

+2.34 (+0.99%)

03/22/22 Mizuho
Puerto Rico tax change could raise Amgen tax rate in 2023, says Mizuho
03/02/22 Citi
Mirati Therapeutics price target lowered to $227 from $244 at Citi
03/01/22 Mizuho
Amgen price target raised to $202 from $194 at Mizuho
03/01/22 Stifel
Stifel upgrades Revolution Medicines, sees good entry point after pullback
AMYT Amryt Pharma
$8.05 /

-0.225 (-2.72%)

03/10/22 H.C. Wainwright
Amryt Pharma price target lowered to $18 from $20 at H.C. Wainwright
03/01/22 Maxim
Amryt Pharma price target lowered to $18 from $27 at Maxim
03/01/22 Canaccord
Amryt Pharma price target lowered to $19 from $40 at Canaccord
03/01/22 H.C. Wainwright
Amryt Pharma price target lowered to $20 from $29 at H.C. Wainwright
BBI Brickell Biotech
/

+

03/08/22 William Blair
Brickell Biotech initiated with an Outperform at William Blair
01/18/22 H.C. Wainwright
Brickell Biotech initiated with a Buy at H.C. Wainwright
09/01/21 Lake Street
Brickell license deal brings 'multiple new value-drivers,' says Lake Street
04/26/21 Lake Street
Brickell Biotech Phase 3 safety results build confidence, says Lake Street
BMY Bristol-Myers
$73.42 /

+1 (+1.38%)

03/21/22 Morgan Stanley
Bristol-Myers' approval of Opdualag as expected, says Morgan Stanley
03/16/22 Canaccord
Nektar price target lowered to $6 from $25 at Canaccord
03/14/22 Cowen
Cowen downgrades Nektar, sees 'high likelihood' of bempeg failure in other uses
03/14/22 Stifel
Nektar downgraded to Hold at Stifel after phase 3 study of bempeg combo fails
RCEL Avita Medical
$7.67 /

-0.185 (-2.36%)

03/01/22 BTIG
Avita Medical price target lowered to $21 from $37 at BTIG
03/01/22 Piper Sandler
Avita Medical price target lowered to $15 from $23 at Piper Sandler
08/27/21 Piper Sandler
Investors should build positions in Avita Medical, says Piper Sandler
06/16/21 Piper Sandler
Avita Medical Q4 results show demand is growing, says Piper Sandler
REGN Regeneron
$683.91 /

+4.48 (+0.66%)

02/23/22 H.C. Wainwright
H.C. Wainwright says Kodiak failure narrows list of rivals for Regeneron's Eylea
02/23/22 Piper Sandler
Regeneron competitor fails to show non-inferiority to Eylea, says Piper Sandler
02/11/22 H.C. Wainwright
Regeneron's Eylea data 'turns up heat' in wet AMD fight, says H.C. Wainwright
02/11/22 Goldman Sachs
Kodiak Sciences initiated with a Buy at Goldman Sachs
SNY Sanofi
$51.44 /

+0.235 (+0.46%)

03/14/22 Stifel
Arvinas lower after analogous Sanofi drug fails, says Stifel
03/02/22 Alliance Global Partners
DarioHealth pact with Sanofi 'potentially game changing,' says Alliance Global
02/28/22 Stifel
Sanofi initiated with a Buy at Stifel
01/25/22 Liberum
Sanofi upgraded to Buy from Hold at Liberum
SSKN Strata Skin Sciences
$1.70 /

+0.05 (+3.03%)

VERO Venus Concept
$1.38 /

-0.015 (-1.08%)

11/12/21 Stifel
Venus Concept price target trimmed to $2 at Stifel after Q3 miss
ASLN Aslan Pharmaceuticals
/

+

09/27/21 Piper Sandler
Piper buyers on Aslan weakness, thinks ASLAN-004 can be competitive
07/09/21 Jefferies
Aslan Pharmaceuticals initiated with a Buy at Jefferies
05/11/21 Piper Sandler
Aslan Pharmaceuticals price target lowered to $8 from $9 at Piper Sandler
CARA Cara Therapeutics
$12.11 /

-0.195 (-1.58%)

03/14/22 Canaccord
Cara Therapeutics price target lowered to $29 from $33 at Canaccord
03/08/22 JPMorgan
Cara Therapeutics upgraded to Overweight from Neutral at JPMorgan
11/01/21 Canaccord
Cara Therapeutics assumed with a Buy at Canaccord
09/28/21 Piper Sandler
Piper Sandler nephrologist survey encouraging for Cara Therapeutics
KRYS Krystal Biotech
$65.98 /

+0.39 (+0.59%)

02/28/22 H.C. Wainwright
Krystal Biotech price target lowered to $107 from $124 at H.C. Wainwright
01/18/22 BofA
Krystal Biotech initiated with a Buy at BofA
01/18/22 BofA
Krystal Biotech initiated with a Buy at BofA
11/29/21 H.C. Wainwright
Krystal Biotech price target raised to $124 from $103 at H.C. Wainwright
IFRX InflaRx
$2.51 /

+0.03 (+1.21%)

02/28/22 Guggenheim
InflaRx cut to Neutral at Guggenheim after 'complete surprise' from FDA
02/28/22 Guggenheim
InflaRx downgraded to Neutral from Buy at Guggenheim
11/15/21 Raymond James
InflaRx's ANCA vasculitis data 'solid,' says Raymond James
10/27/21 Raymond James
Raymond James upgrades InflaRx to Strong Buy after updated PG data
IMUX Immunic
$11.71 /

-0.16 (-1.35%)

02/18/22 Piper Sandler
Piper says baseline demographics give Immunic's CALDOSE trial high odds
02/08/22 Piper Sandler
Piper Sandler more bullish on Immunic ahead of CALDOSE UC study readout
11/19/21 Roth Capital
Roth Capital 'very bullish' on Immunic's IMU-838 in multiple sclerosis
10/27/21 Piper Sandler
Piper says Immunic shares remain undervalued given non-MS pipeline
INCY Incyte
$78.34 /

+0.105 (+0.13%)

02/09/22 SVB Securities
SVB Leerink downgrades Incyte to Underperform, lowers price target to $56
02/09/22 SVB Securities
Incyte downgraded to Underperform from Market Perform at SVB Leerink
01/18/22 RBC Capital
Incyte upgraded to Outperform at RBC Capital on improving 2022 setup
01/18/22 RBC Capital
Incyte upgraded to Outperform from Sector Perform at RBC Capital
BHC Bausch Health
$23.04 /

-0.365 (-1.56%)

02/01/22 RBC Capital
Bausch Health price target lowered to $34 from $40 at RBC Capital
11/03/21 JPMorgan
Bausch Health earnings selloff a buying opportunity, says JPMorgan
09/21/21 JPMorgan
Bausch has 50% upside based on sum-of-the-parts, says JPMorgan
08/04/21 JPMorgan
Bausch Health selloff on Solta IPO plans overdone, says JPMorgan
VERO Venus Concept
$1.38 /

-0.015 (-1.08%)

SSKN Strata Skin Sciences
$1.70 /

+0.05 (+3.03%)

SNY Sanofi
$51.44 /

+0.235 (+0.46%)

REGN Regeneron
$683.91 /

+4.48 (+0.66%)

RCEL Avita Medical
$7.67 /

-0.185 (-2.36%)

KRYS Krystal Biotech
$65.98 /

+0.39 (+0.59%)

INCY Incyte
$78.34 /

+0.105 (+0.13%)

IMUX Immunic
$11.71 /

-0.16 (-1.35%)

IFRX InflaRx
$2.51 /

+0.03 (+1.21%)

CARA Cara Therapeutics
$12.11 /

-0.195 (-1.58%)

BMY Bristol-Myers
$73.42 /

+1 (+1.38%)

BHC Bausch Health
$23.04 /

-0.365 (-1.56%)

BBI Brickell Biotech
/

+

ASLN Aslan Pharmaceuticals
/

+

AMYT Amryt Pharma
$8.05 /

-0.225 (-2.72%)

AMGN Amgen
$239.19 /

+2.34 (+0.99%)

ABBV AbbVie
$161.91 /

+1.65 (+1.03%)

  • 01
    Dec
  • 28
    Oct
  • 15
    Jul
SNY Sanofi
$51.44 /

+0.235 (+0.46%)

REGN Regeneron
$683.91 /

+4.48 (+0.66%)

BMY Bristol-Myers
$73.42 /

+1 (+1.38%)

AMGN Amgen
$239.19 /

+2.34 (+0.99%)

ABBV AbbVie
$161.91 /

+1.65 (+1.03%)

VERO Venus Concept
$1.38 /

-0.015 (-1.08%)

SNY Sanofi
$51.44 /

+0.235 (+0.46%)

REGN Regeneron
$683.91 /

+4.48 (+0.66%)

KRYS Krystal Biotech
$65.98 /

+0.39 (+0.59%)

INCY Incyte
$78.34 /

+0.105 (+0.13%)

BMY Bristol-Myers
$73.42 /

+1 (+1.38%)

BHC Bausch Health
$23.04 /

-0.365 (-1.56%)

BBI Brickell Biotech
/

+

ASLN Aslan Pharmaceuticals
/

+

AMYT Amryt Pharma
$8.05 /

-0.225 (-2.72%)

AMGN Amgen
$239.19 /

+2.34 (+0.99%)

ABBV AbbVie
$161.91 /

+1.65 (+1.03%)

INCY Incyte
$78.34 /

+0.105 (+0.13%)

IFRX InflaRx
$2.51 /

+0.03 (+1.21%)

BMY Bristol-Myers
$73.42 /

+1 (+1.38%)

BHC Bausch Health
$23.04 /

-0.365 (-1.56%)

AMGN Amgen
$239.19 /

+2.34 (+0.99%)

ABBV AbbVie
$161.91 /

+1.65 (+1.03%)

Hot Stocks
Strata Skin Sciences launches Xtrac Momentum 1.0 » 16:54
02/09/22
02/09
16:54
02/09/22
16:54
SSKN

Strata Skin Sciences

$1.63 /

+0.22 (+15.60%)

Skin Sciences announced…

Skin Sciences announced its commercial launch, with the first installation in the U.S. market, of its next generation excimer laser system, Xtrac Momentum 1.0.

ShowHide Related Items >><<
SSKN Strata Skin Sciences
$1.63 /

+0.22 (+15.60%)

SSKN Strata Skin Sciences
$1.63 /

+0.22 (+15.60%)

Syndicate
Strata Skin Sciences files to sell 358K shares of common stock for holders  16:20
01/13/22
01/13
16:20
01/13/22
16:20
SSKN

Strata Skin Sciences

$1.54 /

-0.01 (-0.65%)

 
ShowHide Related Items >><<
SSKN Strata Skin Sciences
$1.54 /

-0.01 (-0.65%)

SSKN Strata Skin Sciences
$1.54 /

-0.01 (-0.65%)

Earnings
Strata Skin Sciences sees FY21 revenue $29.7M-$30.1M, consensus $29.11M » 16:16
01/10/22
01/10
16:16
01/10/22
16:16
SSKN

Strata Skin Sciences

$1.35 /

-0.02 (-1.47%)

The company said,…

The company said, "Preliminary, unaudited total revenue for the full year 2021 is expected to range from $29.7 million to $30.1 million, compared to $23.1 million for the full year 2020."

ShowHide Related Items >><<
SSKN Strata Skin Sciences
$1.35 /

-0.02 (-1.47%)

SSKN Strata Skin Sciences
$1.35 /

-0.02 (-1.47%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.